NEW YORK (GenomeWeb News) – The Women and Infants Hospital of Rhode Island will be using funding from genetic testing firm Natera to study the use of the company's prenatal blood test for Down syndrome and other chromosomal abnormalities in a general clinical setting.

Investigators at the hospital plan to focus their efforts on finding out how much information and education women in the general pregnancy population need about the test, called Panorama, which has been used so far been used to screen women in high-risk groups, the hospital said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.